Diabetic complications and early treatment using ACE inhibitors: concluding remarks.
Mogensen
C E
CE
Medical Department M, (Diabetes and Endocrinology), Aarhus Komune-hospitalet, Denmark.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000401:mortality / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000503:physiopathology / Q000517:prevention & control*; D003930:Diabetic Retinopathy / Q000517:prevention & control; D004232:Diuretics / Q000627:therapeutic use; D005919:Glomerular Filtration Rate; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics